The challenge to patent law of pure chemical protein synthesis

    Research output: Contribution to journalArticle

    1 Citation (Scopus)

    Abstract

    The emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system.

    Original languageEnglish (US)
    Pages (from-to)547-549
    Number of pages3
    JournalNature Biotechnology
    Volume23
    Issue number5
    DOIs
    StatePublished - 2005

    Fingerprint

    Drug Design
    Proteins
    Pharmaceutical Preparations

    ASJC Scopus subject areas

    • Microbiology

    Cite this

    The challenge to patent law of pure chemical protein synthesis. / Fellmeth, Aaron.

    In: Nature Biotechnology, Vol. 23, No. 5, 2005, p. 547-549.

    Research output: Contribution to journalArticle

    @article{986585fff90f4c89a1fc61b4b50926e3,
    title = "The challenge to patent law of pure chemical protein synthesis",
    abstract = "The emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system.",
    author = "Aaron Fellmeth",
    year = "2005",
    doi = "10.1038/nbt0505-547",
    language = "English (US)",
    volume = "23",
    pages = "547--549",
    journal = "Biotechnology",
    issn = "1087-0156",
    publisher = "Nature Publishing Group",
    number = "5",

    }

    TY - JOUR

    T1 - The challenge to patent law of pure chemical protein synthesis

    AU - Fellmeth, Aaron

    PY - 2005

    Y1 - 2005

    N2 - The emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system.

    AB - The emergence of pure chemical protein synthesis as a commercially viable method of drug design and production will create serious problems in the patent system.

    UR - http://www.scopus.com/inward/record.url?scp=22844440439&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=22844440439&partnerID=8YFLogxK

    U2 - 10.1038/nbt0505-547

    DO - 10.1038/nbt0505-547

    M3 - Article

    C2 - 15877067

    AN - SCOPUS:22844440439

    VL - 23

    SP - 547

    EP - 549

    JO - Biotechnology

    JF - Biotechnology

    SN - 1087-0156

    IS - 5

    ER -